MNNGF (Baijin Life Science Holdings) Beginning Cash Position: $6.14 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MNNGF Baijin Life Science Holdings Ltd MNNGF
33 GF Score
Price $0.08
GF Value $0.05
! 4 Warning Signs
View Full Analysis

What is Baijin Life Science Holdings Beginning Cash Position?

Baijin Life Science Holdings MNNGF 33 Beginning Cash Position is $6.14 Mil as of Sep. 2025. GuruFocus rates MNNGF with a GF Score™ of 33/100 and a GF Value™ of $0.05. The stock has 4 warning signs investors should review.

Baijin Life Science Holdings's Beginning Cash Position for the quarter that ended in Sep. 2025 was $6.14 Mil.

Baijin Life Science Holdings's quarterly Beginning Cash Position increased from Sep. 2024 ($4.86 Mil) to Mar. 2025 ($5.71 Mil) and increased from Mar. 2025 ($5.71 Mil) to Sep. 2025 ($6.14 Mil).

Baijin Life Science Holdings's annual Beginning Cash Position increased from Mar. 2023 ($3.01 Mil) to Mar. 2024 ($5.27 Mil) but then declined from Mar. 2024 ($5.27 Mil) to Mar. 2025 ($4.87 Mil).

Baijin Life Science Holdings Beginning Cash Position Related Terms

Baijin Life Science Holdings Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Baijin Life Science Holdings's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baijin Life Science Holdings Beginning Cash Position Chart

Baijin Life Science Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.12 3.01 5.27 4.87 0.00

Baijin Life Science Holdings Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.27 4.86 5.71 6.14 0.00
MNNGF
33GF Score
Baijin Life Science Holdings Ltd MNNGF
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Baijin Life Science Holdings Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $6.14 Mil mean?
Baijin Life Science Holdings (MNNGF) has a Beginning Cash Position of $6.14 Mil as of Sep. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Baijin Life Science Holdings and its competitors.
Is Baijin Life Science Holdings' Beginning Cash Position too high?
Baijin Life Science Holdings' current Beginning Cash Position is $6.14 Mil. Overall, Baijin Life Science Holdings has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Baijin Life Science Holdings' Beginning Cash Position compare to TPR?
Baijin Life Science Holdings' Beginning Cash Position of $6.14 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Retail - Cyclical company?
A good Beginning Cash Position depends on the Retail - Cyclical industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Baijin Life Science Holdings and its competitors. Baijin Life Science Holdings's current Beginning Cash Position is $6.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baijin Life Science Holdings stock overvalued right now?
Baijin Life Science Holdings (MNNGF) has a current Beginning Cash Position of $6.14 Mil. The stock's GF Value™ is $0.05, compared to a current price of $0.08 — trading 50% above its estimated fair value. The current Beginning Cash Position is $6.14 Mil. Baijin Life Science Holdings' overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Baijin Life Science Holdings (MNNGF), the current Beginning Cash Position is $6.14 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Baijin Life Science Holdings (MNNGF) Overvalued in 2026?

Based on GuruFocus' analysis, Baijin Life Science Holdings stock appears to be overvalued. The current stock price of $0.08 is trading 50% above its estimated GF Value™ of $0.05.

Key valuation signals for MNNGF:

  • Beginning Cash Position: $6.14 Mil
  • GF Value™: $0.05 vs. price of $0.08 (50% above fair value)
  • GF Score™: 33/100 with 4 warning signs

No single metric tells the full story. See the MNNGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Baijin Life Science Holdings Business Description

Other Exchanges 01466:Hong Kong
Address 66 Gloucester Road, Office B, 9/F Pico Tower, Wanchai, Hong Kong, HKG
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
33GF Score

Get the complete analysis for MNNGF

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price
$0.05
GF Value